The landscape of GLP-1 therapy continues to evolve rapidly
Mounjaro: A once-weekly injection approved for type 2 diabetes
Whilst once-weekly preparations such as semaglutide and dulaglutide can be administered at any time of day, other formulations have more specific timing requirements
Pairing weight loss medication with professional support , like Ovivas programme, helps you build healthy habits and protect your overall wellbeing
Retatrutide, an innovative agent undergoing Phase III trials for obesity, T2DM, and non-alcoholic fatty liver disease, has demonstrated encouraging outcomes
Once you settle in at your maintenance dose, gastrointestinal side effects should improve and ultimately go away (although for some people, you may feel mild side effects the day after you give yourself the injection)